Category: Finance

Finance

The Valuation of Essex Property Trust Inc (ESS) is Outstanding, so could it Decline?

The real estate sector has been flourishing across the globe since the onset of the 21st Century. This in turn has led to outstanding growth

Finance

West Fraser Timber Co. Ltd. (WFG) in Recess since the start of 2022 despite Solid Indicators

Several years ago, the timber and wood industry was known for making hefty gains on the stock market. But as the world has turned its

Finance

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

PaySign, Inc. (PAYS) stock prices were down 15.0568% early in the trading day on May 12th, 2021, bringing the price per share down to USD$2.99

Business

Cue Biopharma, Inc. (NASDAQ:CUE) stock surged in the current trading session; here’s why

In the current trading session, at the last check, the CUE stock had surged by 29.88% to $14.62. CUE’s stock previously closed at $11.26. The

Finance

Conformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for Identity Imprint

Conformis, Inc. (CFMS) stock prices were up 5.9061% during the first half of the trading day on May 10th, 2021, bringing the price per share

Finance

Auris Medical Inc. (NASDAQ: EARS) stock rises during current market. Why is it so?

Auris Medical Inc. (NASDAQ: EARS) stock gains by 25.08% in the current market trading. Auris Medical is a clinical-stage pharmaceutical organization focused on developing treatments

Finance

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock previously

Finance

A Bet That Definitely Worked; But Persistence Needed: Moleculin Biotech Inc. (MBRX)

Moleculin Biotech, Inc., (Nasdaq: MBRX) shares are trade -2.84% to $4.78. Based on the relationship between its 200-day and 20-day major moving averages, Moleculin Biotech

Finance

Acasti Pharma Inc. (ACST) stock is Bearish after this big Update

Acasti Pharma Inc. (NASDAQ: ACST) (TSX-V: ACST) stock plunged more than 22% in the premarketing today after the news that, since obtaining a subpoena from

Get your daily dose of news with exclusive content, articles, and more at The Market Globalist, a free online newspaper launched in May 2010. They’re young, but ambitious, aiming to deliver engaging and informative content. Contribute your own stories and photos to be part of the community!

Category: Finance

The Valuation of Essex Property Trust Inc (ESS) is Outstanding, so could it Decline?

West Fraser Timber Co. Ltd. (WFG) in Recess since the start of 2022 despite Solid Indicators

PaySign, Inc. (PAYS) Stock Down Following Disclosure of Troubling Q1 2021 Financial Reports

Cue Biopharma, Inc. (NASDAQ:CUE) stock surged in the current trading session; here’s why

Conformis, Inc. (CFMS) Stock Trending Up Following 510(k) Clearance from FDA for Identity Imprint

Auris Medical Inc. (NASDAQ: EARS) stock rises during current market. Why is it so?

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

A Bet That Definitely Worked; But Persistence Needed: Moleculin Biotech Inc. (MBRX)

Acasti Pharma Inc. (ACST) stock is Bearish after this big Update

Quick Links

Categories